))
Additional Advances in NSCLC Research and Clinical Trials With Beth Sandy, MSN, CRNP
Manage episode 357636647 series 3456244
İçerik i3 Health and I3 Health tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan i3 Health and I3 Health veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Click here to view and claim credit for Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer, an accredited CME/NCPD activity provided by i3 Health: i3health.com/nsclc-immunotherapy Just under a year ago, Beth Sandy, MSN, CRNP, a Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Center, co-led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity, Harnessing Immunotherapy-Based Strategies For Advanced Non–Small Cell Lung Cancer (NSCLC). In this interview, she provides an update on advancements made in treatment and supportive care strategies since recording.
…
continue reading
24 bölüm
Paylaş
